Literature DB >> 18501204

Lysophospholipid interactions with protein targets.

Abby L Parrill1.   

Abstract

Bioactive lysophospholipids include lysophosphatidic acid (LPA), sphingosine 1-phosphate (S1P), cyclic-phosphatidic acid (CPA) and alkyl glycerolphosphate (AGP). These lipid mediators stimulate a variety of responses that include cell survival, proliferation, migration, invasion, wound healing, and angiogenesis. Responses to lysophospholipids depend upon interactions with biomolecular targets in the G protein-coupled receptor (GPCR) and nuclear receptor families, as well as enzymes. Our current understanding of lysophospholipid interactions with these targets is based on a combination of lysophospholipid analog structure activity relationship studies as well as more direct structural characterization techniques such as X-ray crystallography, nuclear magnetic resonance (NMR) spectroscopy, and experimentally-validated molecular modeling. The direct structural characterization studies are the focus of this review, and provide the insight necessary to stimulate structure-based therapeutic lead discovery efforts in the future.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18501204      PMCID: PMC2564851          DOI: 10.1016/j.bbalip.2008.04.011

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  106 in total

1.  Functional role of internal water molecules in rhodopsin revealed by X-ray crystallography.

Authors:  Tetsuji Okada; Yoshinori Fujiyoshi; Maria Silow; Javier Navarro; Ehud M Landau; Yoshinori Shichida
Journal:  Proc Natl Acad Sci U S A       Date:  2002-04-23       Impact factor: 11.205

2.  Identification of G protein-coupled receptor genes from the human genome sequence.

Authors:  Shigeki Takeda; Shiro Kadowaki; Tatsuya Haga; Hirotomo Takaesu; Shigeki Mitaku
Journal:  FEBS Lett       Date:  2002-06-05       Impact factor: 4.124

Review 3.  FTY720: targeting G-protein-coupled receptors for sphingosine 1-phosphate in transplantation and autoimmunity.

Authors:  Volker Brinkmann; Kevin R Lynch
Journal:  Curr Opin Immunol       Date:  2002-10       Impact factor: 7.486

4.  Structural basis for antagonist-mediated recruitment of nuclear co-repressors by PPARalpha.

Authors:  H Eric Xu; Thomas B Stanley; Valerie G Montana; Millard H Lambert; Barry G Shearer; Jeffery E Cobb; David D McKee; Cristin M Galardi; Kelli D Plunket; Robert T Nolte; Derek J Parks; John T Moore; Steven A Kliewer; Timothy M Willson; Julie B Stimmel
Journal:  Nature       Date:  2002-02-14       Impact factor: 49.962

5.  A single amino acid determines lysophospholipid specificity of the S1P1 (EDG1) and LPA1 (EDG2) phospholipid growth factor receptors.

Authors:  D A Wang; Z Lorincz; D L Bautista; K Liliom; G Tigyi; A L Parrill
Journal:  J Biol Chem       Date:  2001-10-16       Impact factor: 5.157

6.  Lysophosphatidic acid (LPA) receptors are activated differentially by biological fluids: possible role of LPA-binding proteins in activation of LPA receptors.

Authors:  Kotaro Hama; Koji Bandoh; Yoshiyuki Kakehi; Junken Aoki; Hiroyuki Arai
Journal:  FEBS Lett       Date:  2002-07-17       Impact factor: 4.124

Review 7.  Stereochemical properties of lysophosphatidic acid receptor activation and metabolism.

Authors:  Kazuaki Yokoyama; Daniel L Baker; Tamas Virag; Karoly Liliom; Hoe Sup Byun; Gabor Tigyi; Robert Bittman
Journal:  Biochim Biophys Acta       Date:  2002-05-23

Review 8.  Molecular basis for lysophosphatidic acid receptor antagonist selectivity.

Authors:  Vineet M Sardar; Debra L Bautista; David J Fischer; Kazuaki Yokoyama; Nora Nusser; Tamas Virag; De-an Wang; Daniel L Baker; Gabor Tigyi; Abby L Parrill
Journal:  Biochim Biophys Acta       Date:  2002-05-23

9.  Lysophospholipids in the limelight: autotaxin takes center stage.

Authors:  Wouter H Moolenaar
Journal:  J Cell Biol       Date:  2002-07-22       Impact factor: 10.539

10.  Autotaxin has lysophospholipase D activity leading to tumor cell growth and motility by lysophosphatidic acid production.

Authors:  Makiko Umezu-Goto; Yasuhiro Kishi; Akitsu Taira; Kotaro Hama; Naoshi Dohmae; Koji Takio; Takao Yamori; Gordon B Mills; Keizo Inoue; Junken Aoki; Hiroyuki Arai
Journal:  J Cell Biol       Date:  2002-07-15       Impact factor: 10.539

View more
  16 in total

1.  Ligand-based autotaxin pharmacophore models reflect structure-based docking results.

Authors:  Catrina D Mize; Ashley M Abbott; Samantha B Gacasan; Abby L Parrill; Daniel L Baker
Journal:  J Mol Graph Model       Date:  2011-09-18       Impact factor: 2.518

2.  2D binary QSAR modeling of LPA3 receptor antagonism.

Authors:  James I Fells; Ryoko Tsukahara; Jianxiong Liu; Gabor Tigyi; Abby L Parrill
Journal:  J Mol Graph Model       Date:  2010-03-07       Impact factor: 2.518

Review 3.  Unlocking the biology of RAGE in diabetic microvascular complications.

Authors:  Michaele B Manigrasso; Judyta Juranek; Ravichandran Ramasamy; Ann Marie Schmidt
Journal:  Trends Endocrinol Metab       Date:  2013-09-03       Impact factor: 12.015

4.  Synthesis and pharmacological evaluation of the stereoisomers of 3-carba cyclic-phosphatidic acid.

Authors:  Renuka Gupte; Anjaih Siddam; Yan Lu; Wei Li; Yuko Fujiwara; Nattapon Panupinthu; Truc-Chi Pham; Daniel L Baker; Abby L Parrill; Mari Gotoh; Kimiko Murakami-Murofushi; Susumu Kobayashi; Gordon B Mills; Gabor Tigyi; Duane D Miller
Journal:  Bioorg Med Chem Lett       Date:  2010-10-08       Impact factor: 2.823

5.  Benzyl and naphthalene methylphosphonic acid inhibitors of autotaxin with anti-invasive and anti-metastatic activity.

Authors:  Renuka Gupte; Renukadevi Patil; Jianxiong Liu; Yaohong Wang; Sue C Lee; Yuko Fujiwara; James Fells; Alyssa L Bolen; Karin Emmons-Thompson; C Ryan Yates; Anjaih Siddam; Nattapon Panupinthu; Truc-Chi T Pham; Daniel L Baker; Abby L Parrill; Gordon B Mills; Gabor Tigyi; Duane D Miller
Journal:  ChemMedChem       Date:  2011-04-04       Impact factor: 3.466

6.  Lysophosphatidic acid 2 receptor-mediated supramolecular complex formation regulates its antiapoptotic effect.

Authors:  Shuyu E; Yun-Ju Lai; Ryoko Tsukahara; Chen-Shan Chen; Yuko Fujiwara; Junming Yue; Jei-Hwa Yu; Huazhang Guo; Akio Kihara; Gábor Tigyi; Fang-Tsyr Lin
Journal:  J Biol Chem       Date:  2009-03-17       Impact factor: 5.157

7.  Improved method for the quantification of lysophospholipids including enol ether species by liquid chromatography-tandem mass spectrometry.

Authors:  James G Bollinger; Hiromi Ii; Martin Sadilek; Michael H Gelb
Journal:  J Lipid Res       Date:  2009-08-29       Impact factor: 5.922

Review 8.  Calcium-independent phospholipases in the heart: mediators of cellular signaling, bioenergetics, and ischemia-induced electrophysiologic dysfunction.

Authors:  Ari Cedars; Christopher M Jenkins; David J Mancuso; Richard W Gross
Journal:  J Cardiovasc Pharmacol       Date:  2009-04       Impact factor: 3.105

Review 9.  Lipid phosphate phosphatase (LPP3) and vascular development.

Authors:  H Ren; M Panchatcharam; P Mueller; D Escalante-Alcalde; A J Morris; S S Smyth
Journal:  Biochim Biophys Acta       Date:  2012-07-24

10.  Autotaxin structure-activity relationships revealed through lysophosphatidylcholine analogs.

Authors:  E Jeffrey North; Daniel A Osborne; Peter K Bridson; Daniel L Baker; Abby L Parrill
Journal:  Bioorg Med Chem       Date:  2009-03-21       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.